Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259125 · ClinicalTrials.gov registry record
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 72
- Enrollment target
NCT04259125: Completed study, sponsored by University of California, San Francisco.
NCT04259125 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04259125 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The purpose of this study evaluate the relationship between inflammation and epilepsy in neonates with seizures after birth.
Primary Outcome
Investigators will evaluate the seizure burden from the initial diagnostic electroencephalogram (EEG) after birth by determining the average number of seizures per hour.
Interventions
- DIAGNOSTIC_TEST Blood draw
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2025-12-01 |
What the finished NCT04259125 record still lists
NCT04259125 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT04259125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04259125 about?
NCT04259125 is a clinical study titled "Evaluating the Role of Inflammation in Neonatal Epileptogenesis". The purpose of this study evaluate the relationship between inflammation and epilepsy in neonates with seizures after birth.
What is the current status of trial NCT04259125?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2018-12-15. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT04259125?
The interventions under investigation include: Blood draw (DIAGNOSTIC_TEST), Survey (OTHER).
Who is sponsoring clinical trial NCT04259125?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI